Royal Bank of Canada’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-500
Closed -$9K 6899
2019
Q3
$9K Sell
500
-600
-55% -$12.1K ﹤0.01% 5812
2019
Q2
$24K Buy
1,100
+800
+267% +$16.8K ﹤0.01% 5619
2019
Q1
$7K Sell
300
-100
-25% -$2.28K ﹤0.01% 6131
2018
Q4
$8K Buy
+400
New +$7.13K ﹤0.01% 5984
2016
Q3
Sell
-100,000
Closed -$781K 6435
2016
Q2
$781K Hold
100,000
﹤0.01% 3314
2016
Q1
$400K Hold
100,000
﹤0.01% 3839
2015
Q4
$564K Buy
+100,000
New +$560K ﹤0.01% 3657

Other funds holding EXEL

Royal Bank of Canada's EXEL Position: Q1 2026 in Review

Royal Bank of Canada increased its Exelixis (EXEL) stake by 25% in Q1 2026, buying an estimated $5.89M and bringing the position to 694,131 shares worth $29.8M. The position accounts for 0.01% of the portfolio, ranked #1191.

Royal Bank of Canada first reported a position in EXEL in Q2 2013 and has held it in 52 quarters since. The position peaked at $82M in Q2 2025. 697 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Royal Bank of Canada held 694,131 shares of Exelixis worth $29.8M as of Q1 2026.
  • Royal Bank of Canada bought 136,976 Exelixis shares in Q1 2026, an estimated $5.89M.
  • Exelixis made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1191 holding.
  • Royal Bank of Canada first reported a position in Exelixis in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Exelixis position peaked at $82M in Q2 2025.
  • 697 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.